We spoke with Dr. Sara Tolaney, BCRF investigator and 2025 AACR Outstanding Investigator Award for Breast Cancer Research recipient, at #SABCS25 to unpack key research advances from the conference. Here, she breaks down promising updates on oral SERDs for metastatic hormone receptor–positive breast cancer, including FDA-approved Imlunestrant for ESR1-mutant disease, and emerging evidence that oral SERDs—alone or in combination—may help patients live longer while effectively controlling their can

Thousands of women diagnosed with the early stages of breast cancer could avoid chemotherapy under a new ‘precision medicine’ approach. Breast Cancer Care Nurse Addie says today's news is truly groundbreaking. | This Morning

392K views · 188 reactions | Fatigue is a common warning sign of metastatic breast cancer. See what symptoms should be caught early and the treatment options available. | Nation.com | Facebook